News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
As Pfizer (PFE) Kills Alzheimer's Trial, Axovant (AXON) Stock Plunges     2/3/2016
Denali, Helmed by Former Genentech (RHHBY) Execs, Takes Space in South San Francisco Site     1/20/2016
Pint-Sized Anavex (AVXL) May Soon Have the Data to Prove Biogen (BIIB) and Eli Lilly (LLY)'s Alzheimer's Approach is All Wrong     12/10/2015
Anavex (AVXL) May Have Just Become a Target for Biogen (BIIB) and Eli Lilly (LLY)     12/2/2015
Transition Therapeutics (TTH.TO)'s Alzheimer's Drug Effective in ELND005 Phase II/III Study     10/15/2015
TauRx Completes $135 Million Funding Round to Support Phase III Trials for Key Products     10/8/2015
30-Year-Old Hedge-Fund Whiz Kid’s Axovant (AXON) Starts Alzheimer’s Phase III Trial     10/7/2015
Nestle SA Advances Further into Medicine with Planned Alzheimer's Test     9/23/2015
FORUM Pharma Halts Clinical Trials for Alzheimer’s and Schizophrenia Drug     9/17/2015
Amgen (AMGN) to Help Develop Novartis AG (NVS)'s Alzheimer's and Migraine Drugs     9/3/2015
Eli Lilly (LLY) Cuts Ties With University of California, San Diego (UCSD) on $100 Million Alzheimer’s Program     8/7/2015
Watch Out Gilead (GILD), Investors Feel Vertex (VRTX) May Be Biogen (BIIB)'s Good Fit     8/4/2015
Embattled Vitae Pharma (VTAE) and Boehringer Ingelheim Relationship Takes Another Blow, Drops BACE Inhibitor Program for Alzheimer’s     7/27/2015
As Biogen (BIIB), Eli Lilly (LLY) Fall Short, Roche (RHHBY) Intensifies Work on Two Alzheimer's Drugs     7/23/2015
Biogen (BIIB) and Eli Lilly (LLY)’s Alzheimer’s Drugs Hint At Promise, But Fail To Dazzle     7/23/2015

News from Around the Web
Mercury From Seafood Not Linked To Alzheimer's, Rush University Medical Center Study     2/3/2016
Could Blood Pressure Drugs Help Treat Alzheimer's? Georgetown University Study     2/1/2016
More Evidence Alzheimer's May Get Transmitted Through "Medical Accidents," University of Zurich Study     1/27/2016
Alzheimer's, Other Diseases Linked To Environmental Toxin, Institute For EthnoMedicine Study     1/25/2016
Alzheimer's Diagnosis Complicated By History Of Reading Problems, Stony Brook University Study     1/22/2016
Hacking Your Brain: Neurotech Startups Aim To Treat Depression, Alzheimer’s And Parkinson’s Through Headsets, Cerestim Reveals     1/14/2016
Urine Test For Early Alzheimer's Steps Closer, Monell Chemical Senses Center Study     1/14/2016
Poor Sleep May Actually Set The Stage For Alzheimer's, Oregon Health & Science University (OHSU) Study     1/8/2016
African-Americans More Likely To Develop Alzheimer's Disease Than Caucasians, Emory University Study     12/28/2015
Anemia Linked To Mild Cognitive Impairment, Study Published In Journal Of Alzheimer's Disease     12/17/2015
First Results From Human Young Blood Rejuvenation Trial Expected, Stanford University School of Medicine Reveals     12/16/2015
Stress In Older People Increases Alzheimer's Risk, Albert Einstein College of Medicine Study     12/14/2015
Why Moderate Drinking May Prevent Death From Alzheimer's, University of Southern Denmark Odense Reveals     12/11/2015
Negative Beliefs About Aging Predict Alzheimer’s Disease, Yale University-Led Study     12/8/2015
Genes That Delay Alzheimer's Disease by 17 Years ID'd, Australian National University Scientists Reveal     12/7/2015

Press Releases
Transition Therapeutics (TTH.TO) Announces Second Quarter Fiscal 2016 Financial Results     2/10/2016
ProMis Neurosciences Announces Identification Of A Second Novel Therapeutic Target For Alzheimer's Disease     2/3/2016
Merck & Co. (MRK) Completes Enrollment In Pivotal Phase 3 "EPOCH" Trial Investigating The Efficacy And Safety Of Verubecestat In Patients With Mild-To-Moderate Alzheimer’s Disease     1/28/2016
PsychoGenics Inc. Obtains A License To The Line-41 Mouse Model Of Alzheimer’s Disease     1/27/2016
Biogen (BIIB) 2015 Revenues Increase 11% To $10.8 Billion     1/27/2016
Eli Lilly (LLY) And Roche Diagnostics Corporation (ROG.VX) To Collaborate On Alzheimer's Disease Adjunct Diagnostic Tool     1/27/2016
Alkermes (ALKS) Announces Initiation Of Phase 1 Clinical Study Of New CNS Drug Candidate ALKS 7119     1/25/2016
Institute for EthnoMedicine Release: Environmental Toxin May Increase Risk Of Alzheimer's Disease And Other Neurodegenerative Illnesses, Study Suggests     1/20/2016
PsychoGenics Inc. And The Alzheimer's Drug Discovery Foundation Announce A Risk-Sharing Partnership For Preclinical Studies     1/12/2016
NeuralStem Inc.'s Preclinical Alzheimer's Disease Data Published In Stem Cells Translational Medicine     1/11/2016
Anavex (AVXL) Announces Positive Dose-Response Data For ANAVEX 2-73 In Alzheimer's Disease Patients     1/11/2016
Scintillon Institute Researchers Find Molecular Link Between Diabetes And Alzheimer’s Disease     1/8/2016
AC Immune SA Release: World’s First Clinical Trial For Anti-Abeta Vaccine Targeting Alzheimer’s Disease-Like Characteristics In People With Down Syndrome     1/7/2016
EIP Pharma Announces Scientific Publication Of Results Demonstrating Pro-Cognitive Effects In Aged Rats Of VX-745, A Clinical Stage Selective P38 MAP Kinase Alpha Inhibitor     12/16/2015
GliaCure Completes Successful Proof Of Concept Phase 1b Clinical Trial In Alzheimer's Disease     12/15/2015

//-->